| Ytd | -18.24% | |
| 1y | -26.97% |
| Open | 1.33 | Prev Close | 1.31 | Low | 1.30 | High | 1.34 | Mkt Cap | 139.37M |
| Vol | 1.85M | Avg Vol | 1.63M | EPS | -1.08 | P/E | N/A | Forward P/E | -0.90 |
| Beta | 2.26 | Short Ratio | 4.55 | Inst. Own | 62.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 1.59 | 200-d Avg | 1.77 | 1yr Est | 12.50 |
CRBU News
The heavy selling pressure might have exhausted for Caribou Biosciences (CRBU) as it is technically
BlackRock Inc. purchased a new stake in shares of Caribou Biosciences, Inc. (NASDAQ: CRBU) during th
Top-ranked stocks ALL, W, BILL, TWLO and CRBU are likely to beat on the bottom line in their upcomin
Caribou Biosciences, Inc. (NASDAQ: CRBU - Get Free Report) has been given an average rating of "Mode
B of A Securities analyst Alec Stranahan maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy a
Caribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.24 per share versus the Zacks
Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.24) per share which beat the anal
-- ANTLER phase 1 data presented at EHA 2026 reinforce vispa-cel safety, efficacy, and durability ar
Here is how Caribou Biosciences, Inc. (CRBU) and Bioventus (BVS) have performed compared to their se
BERKELEY, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a lead
-- Single dose of vispa-cel produced durable responses in 2L LBCL patients: 82% ORR, 67% CR rate, an
-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-naïve patients
Caribou Biosciences NASDAQ: CRBU Chief Executive Officer Rachel Haurwitz said the company is advanci
Caribou Biosciences, Inc. (CRBU) Presents at Jefferies Global Healthcare Conference 2026 Transcript
BERKELEY, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leadi
Caribou Biosciences, Inc. (CRBU) Presents at Bank of America Global Healthcare Conference 2026 Trans
BERKELEY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leadi
BERKELEY, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leadi
Caribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.26 per share versus the Zacks
-- Achieved alignment with FDA on pivotal ANTLER-3 trial design for vispa-cel in 2L LBCL -- -- Longe
BERKELEY, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leadi
Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue
Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after ga
Friday's session saw 104 companies set new 52-week lows.
During Wednesday's session, 104 stocks hit new 52-week lows.
On Monday, 198 companies hit new 52-week lows.
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
During Monday's trading, 1214 companies set new 52-week lows.
On Friday, 422 stocks made new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Wednesday's session saw 784 companies set new 52-week lows.
On Tuesday, 242 companies hit new 52-week lows.
During Friday's morning session, 234 stocks hit new 52-week lows.
During Tuesday's session, 454 stocks hit new 52-week lows.
On Friday, 368 stocks hit new 52-week lows.
During Wednesday's morning trading, 400 companies set new 52-week lows.
During Friday's session, 445 companies made new 52-week lows.